Logo
The Nonclinical
Search
Log In
Subscribe
Logo
Search
Oliver Buchannon
Dessi Turner

Board-certified toxicologist disseminating 15+ years of knowledge in nonclinical drug development.

G.L.P ≠ G.O.O.D

Aug 13, 2026

•

2 min read

G.L.P ≠ G.O.O.D

GLP is actually only the beginning...

Dessi Turner
Dessi Turner
The NOAEL is not your starting dose.

Aug 6, 2026

•

1 min read

The NOAEL is not your starting dose.

But it is where you start.

Dessi Turner
Dessi Turner
Rat: Clean. Monkey: Clean. Humans: Liver Injury.

Jul 30, 2026

•

2 min read

Rat: Clean. Monkey: Clean. Humans: Liver Injury.

Wait...this doesn't add up...

Dessi Turner
Dessi Turner
Clinical hold for 15 months?!

Jul 23, 2026

•

2 min read

Clinical hold for 15 months?!

It didn't have to be this way...

Dessi Turner
Dessi Turner
Nobody's funding your molecule anymore.

Jul 16, 2026

•

2 min read

Nobody's funding your molecule anymore.

42 of 68 rounds this year went to drugs already in humans.

Dessi Turner
Dessi Turner
New molecule. No safety map.

Jul 9, 2026

•

2 min read

New molecule. No safety map.

Here's how to create one and secure your road to the clinic.

Dessi Turner
Dessi Turner
$93M bought the asset. Did it buy the IND?

Jul 2, 2026

•

2 min read

$93M bought the asset. Did it buy the IND?

There's always a data package, but that's not the same as IND-ready.

Dessi Turner
Dessi Turner
This week in nonclinical: the fence around your Phase 1, a GLP myth, and a free dosing card

Jun 25, 2026

•

1 min read

This week in nonclinical: the fence around your Phase 1, a GLP myth, and a free dosing card

You think the clinic sets your trial's limits. Find out why it doesn't inside.

Dessi Turner
Dessi Turner
This week in nonclinical: a case study, a map and a poll

Jun 18, 2026

•

1 min read

This week in nonclinical: a case study, a map and a poll

Learn the full nonclinical arc from start to IND

Dessi Turner
Dessi Turner
This week in nonclinical: investor translation, storytelling, and a quiz

Jun 11, 2026

•

1 min read

This week in nonclinical: investor translation, storytelling, and a quiz

You see your data one way — how do others see it?

Dessi Turner
Dessi Turner
This week in nonclinical: DRF design, dose anchoring, and a checklist

Jun 4, 2026

•

1 min read

This week in nonclinical: DRF design, dose anchoring, and a checklist

Spoiler alert: your GLP study isn't your pivotal study.

Dessi Turner
Dessi Turner
This week in nonclinical: pre-CRO playbook, early tox strategy, and a checklist

May 28, 2026

•

1 min read

This week in nonclinical: pre-CRO playbook, early tox strategy, and a checklist

All the things you can do before you get to GLP.

Dessi Turner
Dessi Turner
This week in nonclinical: adverse findings, the 5-question test, and a checklist

May 21, 2026

•

1 min read

This week in nonclinical: adverse findings, the 5-question test, and a checklist

Open to help settle the adversity debate.

Dessi Turner
Dessi Turner
This week in nonclinical: defensible programs, pIND myths, and a human starting dose calculator

May 14, 2026

•

1 min read

This week in nonclinical: defensible programs, pIND myths, and a human starting dose calculator

This is an issue you don't want to miss.

Dessi Turner
Dessi Turner
This week in nonclinical: TK profiles, exposure myths, and a cheat sheet

May 7, 2026

•

1 min read

This week in nonclinical: TK profiles, exposure myths, and a cheat sheet

Here's to finally understanding the anatomy of TK.

Dessi Turner
Dessi Turner
This week in nonclinical: study design, ICH myths, and a free guide

Apr 30, 2026

•

1 min read

This week in nonclinical: study design, ICH myths, and a free guide

Open to level up your study designs.

Dessi Turner
Dessi Turner

Quick Links

Subscribe

Archive

Upgrade

Subscription

Signup

Reset Password

Update Password

Search

Socials

© 2026 The Nonclinical.
beehiivPowered by beehiiv